| Phenotypic characteristics associated with reduced short physical performance battery score in COPD MS Patel, D Mohan, YM Andersson, M Baz, SCS Kon, JL Canavan, ... Chest 145 (5), 1016-1024, 2014 | 80 | 2014 |
| Quantification of lung PET images: challenges and opportunities DL Chen, J Cheriyan, ER Chilvers, G Choudhury, C Coello, M Connell, ... Journal of Nuclear Medicine 58 (2), 201-207, 2017 | 74 | 2017 |
| Surrogate markers of cardiovascular risk and chronic obstructive pulmonary disease: a large case-controlled study M Fisk, CM McEniery, N Gale, K Mäki-Petäjä, JR Forman, M Munnery, ... Hypertension 71 (3), 499-506, 2018 | 65 | 2018 |
| Objectively measured physical activity in patients with COPD: recommendations from an international task force on physical activity H Demeyer, D Mohan, C Burtin, AW Vaes, M Heasley, RP Bowler, ... Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 8 (4 …, 2021 | 54 | 2021 |
| Quantitative analysis of dynamic 18F-FDG PET/CT for measurement of lung inflammation C Coello, M Fisk, D Mohan, FJ Wilson, AP Brown, MI Polkey, I Wilkinson, ... EJNMMI research 7, 1-12, 2017 | 35 | 2017 |
| The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A … M Fisk, J Cheriyan, D Mohan, J Forman, KM Mäki-Petäjä, CM McEniery, ... PloS one 13 (3), e0194197, 2018 | 32 | 2018 |
| Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary disease M Fisk, J Cheriyan, D Mohan, CM McEniery, J Forman, JR Cockcroft, ... Respiratory Research 19, 1-10, 2018 | 28 | 2018 |
| Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD AA Calderon, C Dimond, DF Choy, R Pappu, MA Grimbaldeston, ... European Respiratory Review 32 (167), 2023 | 23 | 2023 |
| Objectively measured physical activity as a COPD clinical trial outcome C Burtin, D Mohan, T Troosters, H Watz, NS Hopkinson, ... Chest 160 (6), 2080-2100, 2021 | 23 | 2021 |
| Short physical performance battery as a practical tool to assess mortality risk in chronic obstructive pulmonary disease JM Fermont, D Mohan, M Fisk, CE Bolton, W Macnee, JR Cockcroft, ... Age and ageing 50 (3), 795-801, 2021 | 23 | 2021 |
| CXCL-8-dependent and-independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin HR Keir, H Richardson, C Fillmore, A Shoemark, AL Lazaar, BE Miller, ... ERJ Open Research 6 (4), 2020 | 21 | 2020 |
| Evaluating the role of inflammation in chronic airways disease: the ERICA study D Mohan, NS Gale, CM McEniery, CE Bolton, JR Cockcroft, W MacNee, ... COPD: Journal of Chronic Obstructive Pulmonary Disease 11 (5), 552-559, 2014 | 21 | 2014 |
| Short physical performance battery: what does each Sub-Test measure in patients with chronic obstructive pulmonary disease? D Mohan, VS Benson, M Allinder, N Galwey, CE Bolton, JR Cockcroft, ... Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 7 (1), 13, 2020 | 20 | 2020 |
| Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study JM Fermont, CE Bolton, M Fisk, D Mohan, W Macnee, JR Cockcroft, ... PloS one 15 (2), e0228940, 2020 | 19 | 2020 |
| Severe asthma and eligibility for biologics in a Brazilian cohort L Marques Mello, KP Viana, F Moraes dos Santos, LTM Saturnino, ... Journal of Asthma 58 (7), 958-966, 2021 | 17 | 2021 |
| Evaluation of losmapimod in patients with chronic obstructive pulmonary disease (COPD) with systemic inflammation stratified using fibrinogen (‘EVOLUTION’): rationale and protocol M Fisk, D Mohan, J Cheriyan, L Yang, J Fuld, CM McEniery, R Tal-Singer, ... Artery Research 8 (1), 24-34, 2014 | 14 | 2014 |
| Consensus recommendations on the use of 18F-FDG PET/CT in lung disease DL Chen, S Ballout, L Chen, J Cheriyan, G Choudhury, AM Denis-Bacelar, ... Journal of Nuclear Medicine 61 (12), 1701-1707, 2020 | 13 | 2020 |
| Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial D Mohan, H Rossiter, H Watz, C Fogarty, RA Evans, W Man, M Tabberer, ... thorax 78 (3), 258-266, 2023 | 12 | 2023 |
| Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational study JM Fermont, M Fisk, CE Bolton, W MacNee, JR Cockcroft, J Fuld, ... BMJ open 10 (12), e038360, 2020 | 11 | 2020 |
| Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study D Mohan, JR Forman, M Allinder, CM McEniery, CE Bolton, JR Cockcroft, ... Thorax 73 (12), 1182-1185, 2018 | 11 | 2018 |
Ruth Tal-SingerTalSi Translational Medicine Consulting, LLCBestätigte E-Mail-Adresse bei enarespiratory.com
